Organization: Health Canada
Year: 2024
Month: August
Request Number: A-2024-000234
Request Summary: Adverse Drug Reactions (ADRs) for VYVANSE. Report numbers: 001078818, 001084076, E2B_06993638. ADRs for C1 Esterase Inhibitor (Human). Report numbers: E2B_07053195, E2B_07025538, E2B_07017197. ADRs for GAMMAGARD LIQUID. Report numbers: 001080211, 001077016, 001080436.
Disposition: Disclosed in part
Number of pages: 143